Piero Ruscitti Selected Research

Adult-Onset Still's Disease

7/2022	Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications.
4/2022	Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease.
2/2022	The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.
3/2021	The Pathogenic Role of Interferons in the Hyperinflammatory Response on Adult-Onset Still's Disease and Macrophage Activation Syndrome: Paving the Way towards New Therapeutic Targets.
1/2021	The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature.
1/2020	The reduction of concomitant glucocorticoids dosage following treatment with IL-1 receptor antagonist in adult onset Still's disease. A systematic review and meta-analysis of observational studies.
1/2020	Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes.
1/2020	Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
1/2020	Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
4/2019	Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Piero Ruscitti Research Topics

Disease

16	Adult-Onset Still's Disease 07/2022 - 01/2014
16	Rheumatoid Arthritis 03/2021 - 03/2014
13	Systemic Scleroderma (Systemic Sclerosis) 10/2022 - 08/2011
9	COVID-19 07/2022 - 01/2020
9	Rheumatic Diseases (Rheumatism) 01/2022 - 03/2014
8	Macrophage Activation Syndrome 10/2022 - 05/2015
8	Arthritis (Polyarthritis) 10/2021 - 05/2013
8	Fibrosis (Cirrhosis) 12/2019 - 01/2014
6	Type 2 Diabetes Mellitus (MODY) 03/2021 - 06/2015
6	Autoimmune Diseases (Autoimmune Disease) 02/2021 - 11/2014
5	Inflammation (Inflammations) 10/2022 - 01/2018
5	Psoriatic Arthritis 01/2021 - 01/2016
5	Hypertension (High Blood Pressure) 12/2020 - 01/2017
4	Fever (Fevers) 10/2022 - 12/2016
4	Exanthema (Rash) 10/2022 - 12/2016
4	Fatigue 07/2022 - 01/2019
4	Insulin Resistance 01/2021 - 04/2018
3	Pain (Aches) 07/2022 - 01/2019
3	Chronic Disease (Chronic Diseases) 07/2022 - 01/2021
3	Lymphadenopathy 01/2020 - 12/2016
3	Atherosclerosis 01/2019 - 10/2017
2	Abdominal Pain (Pain, Abdominal) 10/2022 - 01/2020
2	Hyperferritinemia 07/2022 - 01/2020
2	Cytokine Release Syndrome 07/2022 - 04/2022
2	Serositis 01/2022 - 12/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
2	Neoplasms (Cancer) 01/2021 - 08/2019
2	Proteinuria 01/2021 - 01/2020
2	autosomal dominant familial Periodic fever 01/2021 - 01/2020
2	Necrosis 12/2020 - 01/2019
2	Fibromyalgia (Fibrositis) 11/2020 - 01/2019
2	Amyloidosis 01/2020 - 01/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2017 - 08/2017
1	Arthralgia (Joint Pain) 10/2022
1	Lung Diseases (Lung Disease) 10/2022
1	Vascular Diseases (Vascular Disease) 10/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2022
1	Dermatomyositis (Dermatopolymyositis) 07/2022
1	Septic Shock (Toxic Shock Syndrome) 07/2022
1	Bites and Stings (Sting) 02/2022
1	Axial Spondyloarthritis 01/2022
1	Pericarditis 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021
1	Virus Diseases (Viral Diseases) 03/2021
1	Hematologic Neoplasms (Hematological Malignancy) 03/2021
1	Joint Diseases (Joint Disease) 02/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2021

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 07/2022 - 08/2011
10	Ferritins (Ferritin)IBA 10/2022 - 05/2015
8	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 04/2018
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
6	Antirheumatic Agents (DMARD)IBA 01/2022 - 03/2014
6	InterleukinsIBA 01/2022 - 01/2015
6	C-Reactive ProteinIBA 01/2022 - 08/2017
6	Biological ProductsIBA 03/2021 - 06/2015
6	Interleukin-1 (Interleukin 1)IBA 01/2020 - 06/2015
5	Pharmaceutical PreparationsIBA 03/2021 - 03/2014
4	Tumor Necrosis Factor InhibitorsIBA 03/2021 - 06/2016
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
4	EnzymesIBA 05/2020 - 05/2015
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2019 - 06/2015
3	AntibodiesIBA 07/2022 - 12/2014
3	Interleukin-10 (Interleukin 10)IBA 04/2022 - 07/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2019
3	SteroidsIBA 01/2022 - 02/2017
3	Colchicine FDA LinkGeneric 01/2022 - 01/2020
3	GlucocorticoidsIBA 12/2021 - 01/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 11/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2014
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021 - 01/2019
3	CollagenIBA 01/2021 - 06/2013
3	tocilizumab (atlizumab)FDA Link 11/2020 - 01/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2019 - 06/2016
3	MicroRNAs (MicroRNA)IBA 01/2019 - 10/2018
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2022 - 04/2018
2	InterferonsIBA 02/2022 - 03/2021
2	VaccinesIBA 01/2022 - 12/2021
2	Rituximab (Mabthera)FDA Link 12/2021 - 11/2016
2	Insulin (Novolin)FDA Link 01/2021 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2018
2	Vitamin D FDA LinkGeneric 12/2020 - 07/2019
2	AutoantibodiesIBA 01/2020 - 04/2018
2	AdipokinesIBA 02/2019 - 01/2018
2	CholesterolIBA 10/2017 - 08/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2016 - 08/2011
2	Endothelin-1 (Endothelin 1)IBA 08/2016 - 10/2015
2	macitentanIBA 10/2015 - 09/2015
2	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2015 - 09/2015
2	Methotrexate (Mexate)FDA LinkGeneric 11/2014 - 03/2014
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2022
1	ametantrone (HAQ)IBA 07/2022
1	Messenger RNA (mRNA)IBA 02/2022
1	BNT162 VaccineIBA 01/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2021
1	ChemokinesIBA 02/2021
1	EpitopesIBA 02/2021

Therapy/Procedure

16	Therapeutics 07/2022 - 03/2014
2	Hyperbaric Oxygenation 11/2020 - 01/2019
2	Stem Cell Transplantation 11/2020 - 02/2015
2	Biological Therapy 02/2017 - 05/2015